Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Clinical trial NCT00045526 · COMPLETED

Trial details

NCT number: NCT00045526
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Esophagus Adenocarcinoma of the Gastroesophageal Junction Recurrent Esophageal Cancer Squamous Cell Carcinoma of the Esophagus Stage III Esophageal Cancer Stage IV Esophageal Cancer

Start date: 2002-06-01
Primary completion: 2007-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.